These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. [Combined immunodeficiency due to DOCK8 deficiency. State of the art]. Liquidano-Pérez E; Maza-Ramos G; Yamazaki-Nakashimada MA; Barragán-Arévalo T; Lugo-Reyes SO; Scheffler-Mendoza S; Espinosa-Padilla SE; González-Serrano ME Rev Alerg Mex; 2022 Jul; 69(1):31-47. PubMed ID: 36927749 [TBL] [Abstract][Full Text] [Related]
43. Inborn Error of Immunity or Atopic Dermatitis: When to be Concerned and How to Investigate. Stadler PC; Renner ED; Milner J; Wollenberg A J Allergy Clin Immunol Pract; 2021 Apr; 9(4):1501-1507. PubMed ID: 33548520 [TBL] [Abstract][Full Text] [Related]
44. Clearance of atypical cutaneous manifestations of hyper-IgE syndrome with dupilumab. Nihal A; Comstock JR; Holland KE; Singh AM; Seroogy CM; Arkin LM Pediatr Dermatol; 2022 Nov; 39(6):940-942. PubMed ID: 35734823 [TBL] [Abstract][Full Text] [Related]
46. Hyper IgE Syndrome in an Isolated Population in Israel. Lachover-Roth I; Lagovsky I; Shtorch-Asor A; Confino-Cohen R; Reinstein E; Garty BZ Front Immunol; 2022; 13():829239. PubMed ID: 35185921 [TBL] [Abstract][Full Text] [Related]
47. [Hyper-IgE syndrome with mutation in STAT3 gene - case report and literature review]. Heropolitańska-Pliszka E; Pietrucha B; Mikołuć B; Bernatowska E Med Wieku Rozwoj; 2009; 13(1):19-25. PubMed ID: 19648655 [TBL] [Abstract][Full Text] [Related]
48. The hyper-IgE syndromes. Freeman AF; Holland SM Immunol Allergy Clin North Am; 2008 May; 28(2):277-91, viii. PubMed ID: 18424333 [TBL] [Abstract][Full Text] [Related]
49. Clinical Manifestations and Genetic Analysis of 17 Patients with Autosomal Dominant Hyper-IgE Syndrome in Mainland China: New Reports and a Literature Review. Wu J; Chen J; Tian ZQ; Zhang H; Gong RL; Chen TX; Hong L J Clin Immunol; 2017 Feb; 37(2):166-179. PubMed ID: 28197791 [TBL] [Abstract][Full Text] [Related]
50. Diminished allergic disease in patients with STAT3 mutations reveals a role for STAT3 signaling in mast cell degranulation. Siegel AM; Stone KD; Cruse G; Lawrence MG; Olivera A; Jung MY; Barber JS; Freeman AF; Holland SM; O'Brien M; Jones N; Nelson CG; Wisch LB; Kong HH; Desai A; Farber O; Gilfillan AM; Rivera J; Milner JD J Allergy Clin Immunol; 2013 Dec; 132(6):1388-96. PubMed ID: 24184145 [TBL] [Abstract][Full Text] [Related]
51. Genetic, clinical, and laboratory markers for DOCK8 immunodeficiency syndrome. Zhang Q; Davis JC; Dove CG; Su HC Dis Markers; 2010; 29(3-4):131-9. PubMed ID: 21178272 [TBL] [Abstract][Full Text] [Related]
52. A novel STAT3 mutation associated with hyper immunoglobulin E syndrome with a paucity of connective tissue signs. Yoshida Y; Nagamori T; Takahashi H; Ishibazawa E; Shimada S; Kawai T; Azuma H Pediatr Int; 2021 May; 63(5):510-515. PubMed ID: 32920916 [TBL] [Abstract][Full Text] [Related]
53. Omalizumab in the Treatment of Hyper-IgE Syndrome: 2 Case Reports. Gomes N; Miranda J; Lopes S; Carneiro-Leão L; Torres Costa J; Baudrier T; Azevedo F J Investig Allergol Clin Immunol; 2020; 30(3):191-192. PubMed ID: 31820738 [No Abstract] [Full Text] [Related]
55. Hyper-IgE syndromes: recent advances in pathogenesis, diagnostics and clinical care. Farmand S; Sundin M Curr Opin Hematol; 2015 Jan; 22(1):12-22. PubMed ID: 25469836 [TBL] [Abstract][Full Text] [Related]
56. Phenotyping and long-term follow up of patients with hyper IgE syndrome. Alyasin S; Esmaeilzadeh H; Ebrahimi N; Nabavizadeh SH; Kashef S; Esmaeilzadeh E; Babaei M; Amin R Allergol Immunopathol (Madr); 2019; 47(2):152-158. PubMed ID: 30279075 [TBL] [Abstract][Full Text] [Related]
57. Hyper-IgE and Carcinoma in CADINS Disease. Pietzsch L; Körholz J; Boschann F; Sergon M; Dorjbal B; Yee D; Gilly V; Kämmerer E; Paul D; Kastl C; Laass MW; Berner R; Jacobsen EM; Roesler J; Aust D; Lee-Kirsch MA; Snow AL; Schuetz C Front Immunol; 2022; 13():878989. PubMed ID: 35651609 [TBL] [Abstract][Full Text] [Related]
58. Genetic Analysis of a Cohort of 275 Patients with Hyper-IgE Syndromes and/or Chronic Mucocutaneous Candidiasis. Frede N; Rojas-Restrepo J; Caballero Garcia de Oteyza A; Buchta M; Hübscher K; Gámez-Díaz L; Proietti M; Saghafi S; Chavoshzadeh Z; Soler-Palacin P; Galal N; Adeli M; Aldave-Becerra JC; Al-Ddafari MS; Ardenyz Ö; Atkinson TP; Kut FB; Çelmeli F; Rees H; Kilic SS; Kirovski I; Klein C; Kobbe R; Korganow AS; Lilic D; Lunt P; Makwana N; Metin A; Özgür TT; Karakas AA; Seneviratne S; Sherkat R; Sousa AB; Unal E; Patiroglu T; Wahn V; von Bernuth H; Whiteford M; Doffinger R; Jouhadi Z; Grimbacher B J Clin Immunol; 2021 Nov; 41(8):1804-1838. PubMed ID: 34390440 [TBL] [Abstract][Full Text] [Related]
59. Hyper IgE syndrome: an update on clinical aspects and the role of signal transducer and activator of transcription 3. Paulson ML; Freeman AF; Holland SM Curr Opin Allergy Clin Immunol; 2008 Dec; 8(6):527-33. PubMed ID: 18978467 [TBL] [Abstract][Full Text] [Related]
60. Mutations in STAT3 and diagnostic guidelines for hyper-IgE syndrome. Woellner C; Gertz EM; Schäffer AA; Lagos M; Perro M; Glocker EO; Pietrogrande MC; Cossu F; Franco JL; Matamoros N; Pietrucha B; Heropolitańska-Pliszka E; Yeganeh M; Moin M; Español T; Ehl S; Gennery AR; Abinun M; Breborowicz A; Niehues T; Kilic SS; Junker A; Turvey SE; Plebani A; Sánchez B; Garty BZ; Pignata C; Cancrini C; Litzman J; Sanal O; Baumann U; Bacchetta R; Hsu AP; Davis JN; Hammarström L; Davies EG; Eren E; Arkwright PD; Moilanen JS; Viemann D; Khan S; Maródi L; Cant AJ; Freeman AF; Puck JM; Holland SM; Grimbacher B J Allergy Clin Immunol; 2010 Feb; 125(2):424-432.e8. PubMed ID: 20159255 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]